Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Illumina Inc (ILMN)

Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,633,922
  • Shares Outstanding, K 152,900
  • Annual Sales, $ 4,343 M
  • Annual Income, $ 850,000 K
  • EBIT $ 817 M
  • EBITDA $ 1,087 M
  • 60-Month Beta 1.45
  • Price/Sales 4.33
  • Price/Cash Flow 18.30
  • Price/Book 6.90

Options Overview Details

View History
  • Implied Volatility 47.56% (+2.55%)
  • Historical Volatility 44.81%
  • IV Percentile 63%
  • IV Rank 26.19%
  • IV High 84.13% on 04/08/25
  • IV Low 34.59% on 11/14/25
  • Expected Move (DTE 22) 10.07 (8.31%)
  • Put/Call Vol Ratio 0.49
  • Today's Volume 67
  • Volume Avg (30-Day) 2,530
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 35,937
  • Open Int (30-Day) 27,689
  • Expected Range 111.09 to 131.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.06
  • Number of Estimates 7
  • High Estimate 1.12
  • Low Estimate 1.04
  • Prior Year 0.97
  • Growth Rate Est. (year over year) +9.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
112.65 +8.30%
on 02/12/26
153.48 -20.51%
on 01/27/26
-31.00 (-20.26%)
since 01/26/26
3-Month
112.65 +8.30%
on 02/12/26
155.53 -21.56%
on 01/22/26
-7.81 (-6.02%)
since 11/26/25
52-Week
68.70 +77.58%
on 04/09/25
155.53 -21.56%
on 01/22/26
+27.95 (+29.72%)
since 02/26/25

Most Recent Stories

More News
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics

At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions

ILMN : 122.05 (+0.15%)
Illumina launches TruPath Genome, setting a new standard in genomic insight

SAN DIEGO , Feb. 24, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of TruPath™ Genome, setting a new standard for high-quality, comprehensive whole genome insights...

ILMN : 122.05 (+0.15%)
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility

40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaS eq X systems , advancing...

ILMN : 122.05 (+0.15%)
Illumina To Webcast Upcoming Investor Conference

SAN DIEGO , Feb. 17, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference:

ILMN : 122.05 (+0.15%)
1 Healthcare Stock Worth Your Attention and 2 Facing Challenges

1 Healthcare Stock Worth Your Attention and 2 Facing Challenges

ILMN : 122.05 (+0.15%)
MOH : 145.29 (-0.18%)
REGN : 762.84 (-2.73%)
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call

5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call

ILMN : 122.05 (+0.15%)
Stocks Roar Back as Beaten-Down Tech Sector Rebounds

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +1.97%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +2.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.15%. March E-mini S&P...

MSTR : 131.40 (-3.13%)
AMAT : 368.36 (-6.73%)
AVGO : 308.22 (-7.25%)
HIMS : 15.87 (+0.32%)
GLXY : 21.77 (-4.64%)
$IUXX : 24,905.68 (-1.67%)
COIN : 179.93 (-2.18%)
ASML : 1,436.84 (-5.87%)
ZNM26 : 113-125 (+0.25%)
ESH26 : 6,880.00 (-1.15%)
STX : 394.00 (-6.60%)
AMD : 201.91 (-4.24%)
Stocks Supported by Tech Strength and Improvement in Consumer Sentiment

The S&P 500 Index ($SPX ) (SPY ) today is up +1.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.93%. March E-mini S&P futures (ESH26...

MSTR : 131.40 (-3.13%)
AMAT : 368.36 (-6.73%)
AVGO : 308.22 (-7.25%)
HIMS : 15.87 (+0.32%)
GLXY : 21.77 (-4.64%)
$IUXX : 24,905.68 (-1.67%)
COIN : 179.93 (-2.18%)
ASML : 1,436.84 (-5.87%)
ZNM26 : 113-125 (+0.25%)
ESH26 : 6,880.00 (-1.15%)
AMD : 201.91 (-4.24%)
BILL : 44.21 (+2.34%)
Stocks Rebound on Positive Tech Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up +1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. March E-mini S&P futures (ESH26...

MSTR : 131.40 (-3.13%)
AMAT : 368.36 (-6.73%)
AVGO : 308.22 (-7.25%)
BE : 159.02 (-9.01%)
HIMS : 15.87 (+0.32%)
GLXY : 21.77 (-4.64%)
$IUXX : 24,905.68 (-1.67%)
COIN : 179.93 (-2.18%)
ZNM26 : 113-125 (+0.25%)
ESH26 : 6,880.00 (-1.15%)
WDC : 272.74 (-6.26%)
AMD : 201.91 (-4.24%)
ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum

ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum

ILMN : 122.05 (+0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies, the company provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies,...

See More

Key Turning Points

3rd Resistance Point 126.78
2nd Resistance Point 125.40
1st Resistance Point 123.64
Last Price 122.05
1st Support Level 120.49
2nd Support Level 119.11
3rd Support Level 117.35

See More

52-Week High 155.53
Fibonacci 61.8% 122.36
Last Price 122.05
Fibonacci 50% 112.11
Fibonacci 38.2% 101.87
52-Week Low 68.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar